Endocrine Abstracts

Polycystic ovary syndrome (PCOS) is an endocrine disorder with a pathogenesis in which hormonal and metabolic disturbances have been considered. There is evidence of a familial aggregation of hormonal and metabolic abnormalities in siblings of PCOS women. Some of the female relatives fulfill the diagnostic criteria of PCOS. Premature balding in the age of <30 has been proposed as the male phenotype in PCOS families.The aim of the study was to determi...

Polycystic ovary syndrome (PCOS) is an endocrine disorder in women of reproductive age. Hormonal disturbances, metabolic disorders, and more recently, chronic inflammation have been considered in pathogenesis of PCOS. One of the determinants of inflammation investigated in terms of insulin resistance (IR) is paraoxonase 1 (PON1).Aim: To evaluate PCOS patients for the existence of chronic inflammation and to assess the relationship among PON1 polymorphism...

Results of many studies indicate that the BsmI polymorphism in the vitamin D receptor (VDR) gene may influence bone tissue metabolism and may be useful in identifying patients at greater risk of osteoporosis. As far as long-term glucocorticoid treatment is a major risk factor for osteoporosis development, we looked for the BsmI VDR gene polymorphism and its relation to phenotypic features characterizing bone status (BMD and metabolic bone turnover) in 74 premenopausal women: 5...

Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women of reproductive age characterized by chronic anovulation and hyperandrogenism, and also associated with insulin resistance. Subclinical chronic inflammation might be an important pathogenetic factor in the development of insulin resistance, type 2 diabetes and recently has been also observed in PCOS. There is evidence for a familial predisposition not only to hormonal abnormalities but also to metabolic d...

Introduction: Results of many studies indicate that BsmI polymorphism in VDR gene may influence bone tissue metabolism and may be useful in identifying patients at greater risk of glucocorticoid-induced osteoporosis.Aim of the study: To determine frequency of polymorphic variants of VDR gene (BsmI) and its relationship to phenotypic features characterizing bone status (BMD and metabolic bone turnover).Material and methods: Followin...

In the 1980s the concept, that some individuals with normal weight (Metabolically Obese, Normal-Weight) have disturbances of metabolism, related to obesity was proposed. It is known, that obesity promotes atheromatosis by various mechanism, inter alia due to excess of inflammatory markers. This problem however, was not investigated in non-obese subjects.We analyzed anthropometric variables, body fat distribution by DXA and serum CRP, Il-6 and Il-18 in 43...

Plasticisers such as bisphenol A (BPA), bisphenol S (BPS), and phthalates (PAE) are commonly used in daily life in electronic equipment, cans, plastic food containers, and bottles. These substances can interact with oestrogen receptors as well as androgen receptors and therefore they are called endocrine disrupting chemicals (EDC). The aim of this study was to evaluate serum concentrations of BPA, BPS, and selected PAE in healthy women and women with polycystic ovary syndrome ...

Polycystic ovary syndrome (PCOS) is the most common endocrinopathy in women of reproductive age, that lead to infertility, type 2 diabetes and coronary heart disease.Bisphenol A (BPA) is one of the most abundant chemicals produced worldwide and is used as a plasticizer in daily life. Nowadays it is also well know that it can interact with estrogen receptors, androgen receptors and peroxisome proliferator-activated receptors γ (PPARγ). Therefore...

The endocannabinoid system has been suspected to contribute to the association of visceral fat accumulation with metabolic diseases. Insulin resistance play important role in etiology in PCOS. The aim of our study was developed the role of CNR1 polymorphisms (rs806368, rs12720071, rs1049353, 806381, rs10485170, rs6454674, rs2023239) in metabolic disorders in woman with PCOS. 88 woman (20–35 years old) with PCOS (recognized using Rotterdam criteria) and 77 woman (20–3...